{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T19:16:04Z","timestamp":1775330164885,"version":"3.50.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2019.00345","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T12:35:46Z","timestamp":1572957346000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates From Patients With Tuberculosis to 12 Antituberculous Drugs in China"],"prefix":"10.3389","volume":"9","author":[{"given":"Xiaocui","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangkun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haican","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinjuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongliang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoshan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangyou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1128\/AAC.42.5.1295","article-title":"Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis","volume":"42","author":"Alangaden","year":"1998","journal-title":"Antimicrob. Agents Chemother"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1128\/JCM.02048-12","article-title":"Evaluation of the sensititre MycoTB plate for susceptibility testing of the Mycobacterium tuberculosis complex against first- and second-line agents","volume":"50","author":"Hall","year":"2012","journal-title":"J. Clin. Microbiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"7104","DOI":"10.1128\/AAC.01117-15","article-title":"Sensititre MycoTB plate compared to bactec MGIT 960 for first- and second-line antituberculosis drug susceptibility testing in tanzania: a call to operationalize MICs","volume":"59","author":"Heysell","year":"2015","journal-title":"Antimicr. Agents Chemother"},{"key":"B4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1089\/mdr.2006.12.7","article-title":"Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility","volume":"12","author":"Kam","year":"2006","journal-title":"Microbial Drug Resist"},{"key":"B5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2147\/IDR.S188538","article-title":"Drug resistance profiles and trends in drug-resistant tuberculosis at a major hospital in Guizhou Province of China","volume":"12","author":"Lan","year":"2019","journal-title":"Infect. Drug Resist"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.hrtlng.2008.05.009","article-title":"Risk factors for multidrug-resistant tuberculosis in Hong Kong","volume":"12","author":"Law","year":"2008","journal-title":"Int. J. Tuberc. Lung. Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1128\/AAC.01209-13","article-title":"Sensititre MYCOTB MIC plate for testing mycobacterium tuberculosis susceptibility to first- and second-line drugs","volume":"58","author":"Lee","year":"2014","journal-title":"Antimicrob. Agents Chemother"},{"key":"B8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13756-018-0348-7","article-title":"Prevalence and patterns of drug resistance among pulmonary tuberculosis patients in Hangzhou, China","volume":"7","author":"Li","year":"2018","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"B9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12879-016-1441-2","article-title":"Characterization of Mycobacterium tuberculosis isolates from Hebei, China: genotypes and drug susceptibility phenotypes","volume":"16","author":"Li","year":"2016","journal-title":"BMC Infect. Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1186\/s12879-018-3578-7","article-title":"Characterization of Mycobacterium tuberculosis strains in Beijing, China: drug susceptibility phenotypes and Beijing genotype family transmission","volume":"18","author":"Liu","year":"2018","journal-title":"BMC Infect. Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.7164\/antibiotics.34.1033","article-title":"New rifamycins modified at positions 3 and 4. Synthesis, structure and biological evaluation","volume":"34","author":"Marsili","year":"1981","journal-title":"J. Antibiot"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0167093","DOI":"10.1371\/journal.pone.0167093","article-title":"A comparison of the sensititre MycoTB plate, the bactec MGIT 960, and a microarray-based molecular assay for the detection of drug resistance in clinical Mycobacterium tuberculosis isolates inMoscow, Russia","volume":"11","author":"Mokrousov","year":"2016","journal-title":"PLoS ONE"},{"key":"B13","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/1471-2334-13-432","article-title":"Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania","volume":"13","author":"Mpagama","year":"2013","journal-title":"BMC Infect. Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1056\/NEJM199806043382301","article-title":"Global surveillance for antituberculosisdrug resistance, 1994-1997. World health organization-international union against tuberculosis and lung disease working group on antituberculosis drug resistance surveillance","volume":"338","author":"Pablos-Mendez","year":"1998","journal-title":"N. Engl. J. Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e105214","DOI":"10.1371\/journal.pone.0105214","article-title":"Development of multidrug resistant tuberculosis in Bangladesh: a case-control study on risk factors","volume":"9","author":"Rifat","year":"2014","journal-title":"PLoS ONE"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e59414","DOI":"10.1371\/journal.pone.0059414","article-title":"The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks","volume":"8","author":"Sirgel","year":"2013","journal-title":"PLoS ONE"},{"key":"B17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/1471-2180-14-165","article-title":"Molecular characterization of amikacin, kanamycin and capreomycin resistance in M\/XDR-TB strains isolated in Thailand","volume":"14","author":"Sowajassatakul","year":"2014","journal-title":"BMC Microbiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0147529","DOI":"10.1371\/journal.pone.0147529","article-title":"Pattern of drug resistance and risk factors associated with development of drug resistantMycobacterium tuberculosis in Pakistan","volume":"11","author":"Ullah","year":"2016","journal-title":"PLoS ONE"},{"key":"B19","volume-title":"Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes, 2nd Edn","author":"Woods","year":"2011"},{"key":"B20","volume-title":"Treatment of Tuberculosis Guidelines for National Programmes, 4th Edn","year":"2010"},{"key":"B21","unstructured":"Global Tuberculosis Report 20182018"},{"key":"B22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1473-3099(16)30418-2","article-title":"Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation","volume":"17","author":"Yang","year":"2017","journal-title":"Lancet Infect. Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12866-016-0699-2","article-title":"Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012","volume":"16","author":"Yin","year":"2016","journal-title":"BMC Microbiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.5588\/ijtld.15.0573","article-title":"SensititreR MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates","volume":"20","author":"Yu","year":"","journal-title":"Int. J. Tuberculosis Lung Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.1128\/AAC.00393-16","article-title":"Wildtype and non-wild-type Mycobacterium tuberculosis MIC distributions for the novel fluoroquinolone antofloxacin compared with those for ofloxacin, levofloxacin, and moxifloxacin","volume":"60","author":"Yu","year":"","journal-title":"Antimicrob. Agents Chemother"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","article-title":"National survey of drug-resistant tuberculosis in China","volume":"366","author":"Zhao","year":"2012","journal-title":"N. Engl. J.Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0209902","DOI":"10.1371\/journal.pone.0209902","article-title":"Drug resistance characteristics of Mycobacterium tuberculosis isolates between 2014 and 2017 in Sichuan, China: a retrospective study","volume":"13","author":"Zhou","year":"2018","journal-title":"PLoS ONE"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2019.00345\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T12:35:49Z","timestamp":1572957349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2019.00345\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,5]]},"references-count":27,"alternative-id":["10.3389\/fcimb.2019.00345"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2019.00345","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,5]]},"article-number":"345"}}